Cargando…
Precision regenerative medicine
BACKGROUND: Precision or individualized medicine is increasingly pervasive across medical and surgical disciplines. However, the concept has not been introduced in regenerative medicine. MAIN BODY: Targeted and engineered cellular and acellular therapy, specific to individuals or disease states, cou...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791634/ https://www.ncbi.nlm.nih.gov/pubmed/33413590 http://dx.doi.org/10.1186/s13287-020-02092-w |
_version_ | 1783633633927495680 |
---|---|
author | Lightner, Amy L. Chan, Timothy |
author_facet | Lightner, Amy L. Chan, Timothy |
author_sort | Lightner, Amy L. |
collection | PubMed |
description | BACKGROUND: Precision or individualized medicine is increasingly pervasive across medical and surgical disciplines. However, the concept has not been introduced in regenerative medicine. MAIN BODY: Targeted and engineered cellular and acellular therapy, specific to individuals or disease states, could significantly improve the efficacy of these autologous therapies. Currently, generic mesenchymal stem cell therapy is being widely used across multiple pathologies, some of which may not respond well to mesenchymal stem cell therapy. Engineered cell therapy may be a way to address this generic one-size-fits-all approach. CONCLUSIONS: The future of regenerative medicine lies in the concept of precision cell-based therapy. |
format | Online Article Text |
id | pubmed-7791634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77916342021-01-11 Precision regenerative medicine Lightner, Amy L. Chan, Timothy Stem Cell Res Ther Viewpoint BACKGROUND: Precision or individualized medicine is increasingly pervasive across medical and surgical disciplines. However, the concept has not been introduced in regenerative medicine. MAIN BODY: Targeted and engineered cellular and acellular therapy, specific to individuals or disease states, could significantly improve the efficacy of these autologous therapies. Currently, generic mesenchymal stem cell therapy is being widely used across multiple pathologies, some of which may not respond well to mesenchymal stem cell therapy. Engineered cell therapy may be a way to address this generic one-size-fits-all approach. CONCLUSIONS: The future of regenerative medicine lies in the concept of precision cell-based therapy. BioMed Central 2021-01-07 /pmc/articles/PMC7791634/ /pubmed/33413590 http://dx.doi.org/10.1186/s13287-020-02092-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Viewpoint Lightner, Amy L. Chan, Timothy Precision regenerative medicine |
title | Precision regenerative medicine |
title_full | Precision regenerative medicine |
title_fullStr | Precision regenerative medicine |
title_full_unstemmed | Precision regenerative medicine |
title_short | Precision regenerative medicine |
title_sort | precision regenerative medicine |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791634/ https://www.ncbi.nlm.nih.gov/pubmed/33413590 http://dx.doi.org/10.1186/s13287-020-02092-w |
work_keys_str_mv | AT lightneramyl precisionregenerativemedicine AT chantimothy precisionregenerativemedicine |